NASDAQ:BCYC - Bicycle Therapeutics News Headlines

$9.75

+0.62 (+6.79 %)

(As of 09/15/2019 04:00 PM ET)

Add

Today's Range

$9.26

Now: $9.75▼

$11.00

50-Day Range

$6.58

MA: $7.66▼

$10.12

52-Week Range

$6.24

Now: $9.75▼

$14.91

Volume40,354 shs

Average Volume19,525 shs

Market Capitalization$172.58 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Source:

Date	Headline
	Goldman Sachs Group Upgrades Bicycle Therapeutics (NASDAQ:BCYC) to "Buy" www.americanbankingnews.com - September 11 at 8:05 AM
	Bicycle Therapeutics Reports Second Quarter 2019 Financial Results and Provides Clinical Update finance.yahoo.com - August 8 at 12:23 PM
	Bicycle Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference www.finanznachrichten.de - August 1 at 8:57 AM
	Bicycle Therapeutics Enhances Board of Directors finance.yahoo.com - July 24 at 3:22 PM
	BICYCLE THERAPEUTICS PLC ADR www.finanznachrichten.de - July 1 at 3:17 PM
	Bicycle Therapeutics Trades Higher On Positive Early-Stage Trial Results For Diabetic Macular Edema Therapy www.benzinga.com - July 1 at 3:17 PM
	Bicycle Therapeutics up 10% premarket on positive THR-149 data seekingalpha.com - July 1 at 3:17 PM
	Bicycle Therapeutics Announces Positive Topline Results from Oxurion’s Phase I Trial Using a Novel Bicycle-based Plasma Kallikrein Inhibitor for the Treatment of Diabetic Macular Edema finance.yahoo.com - July 1 at 3:17 PM
	Bicycle Therapeutics shares soar 29% premarket on news of positive trial of DME treatment finance.yahoo.com - July 1 at 3:17 PM
	Oxurion NV Reports Positive Topline Phase 1 Results with THR-149, a novel, potent plasma kallikrein inhibitor for the treatment www.globenewswire.com - July 1 at 5:52 AM
	Bicycle Therapeutics plc (BCYC) finance.yahoo.com - June 19 at 9:47 AM
	Bicycle Therapeutics shares slide 10.7% in trading debut finance.yahoo.com - June 3 at 9:28 AM

This page was last updated on 9/15/2019 by MarketBeat.com Staff

Headlines